Council Members in this Study Group: 180
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Obstetrician and Gynecologist
ALAN B PATTERSON MD, PA ![]()
Alan Patterson, MD, is an Obstetrician and Gynecologist at Alan B Patterson MD, a private practice in Florida, since May 1991. Dr. Patterson was on the teaching staff at Methodist Hospital, Indianapolis, where he wrote many protocols for the residency program. In the past few years, Dr. Patterson has...
Marina Raikhel, MDDirector
TORRANCE MEMORIAL MEDICAL CENTER ![]()
Marina Raikhel, MD, is an active family practitioner with a particular interest in primary care and ob/gyn focus. She has expertise in the treatment of a wide variety of internal medicine conditions, with special focus on diabetes, hypertension, obesity, anxiety, and depression. She is Director ofTorrance...
Department Chair of Infectious Diseases
SPRINGFIELD CLINIC LLP ![]()
Donald Graham, MD, is Chairman of the Department of Infectious Diseases at the Springfield Clinic in Illinois. He is also Clinical Professor of Medicine at Southern Illinois University School of Medicine. Dr. Graham serves as Medical Advisor of the Sangamon County Department of Public Health. He has...
Jeffrey WeinbergDirector of Clinical Research - Dermatology
ST LUKE'S-ROOSEVELT HOSPITAL CENTER ![]()
Jeffrey Weinberg, MD, is Director of the Clinical Research Center in the Department of Dermatology at St. Luke's-Roosevelt Hospital Center and Beth Israel Medical Center, both of which are part of the Continuum Health Partners hospital system in New York. He is also an Assistant Clinical Professorin...
Director
CALIFORNIA PACIFIC MEDICAL CENTER ![]()
Lowell Young, MD, is Director of the Kuzell Institute for Arthritis & Infectious Diseases at the California Pacific Medical Center Research Institute in San Francisco. Dr. Young is also Attending Physician and Clinical Professor at the University of California’s San Francisco Medical Center. He is...
Cardiac, Thoracic and Vascular Surgeon
Rubenstein Cardiovascular and Thoracic Surgery ![]()
Forrest Rubenstein, MD, FACS, is a Cardiac, Thoracic and Vascular Surgeon in private practice. Dr. Rubenstein is board certified in General, Cardiovascular and Thoracic Surgery. He has experience in cardiac, thoracic and vascular surgery, aortic surgery, trauma, endovascular surgery, drug eluting stents,...
Peter Bornstein, MDPartner and Consultant in Infectious Diseases
St. Paul Infectious Disease Associates, Ltd ![]()
Peter Bornstein, MD, is a Partner and Consultant in Infectious Diseases at St. Paul Infectious Disease Associates, Ltd., in St. Paul, Minnesota. Dr. Bornstein is the Chief of Staff at St. John's Hospital, Maplewood, MN. He spends most of his time seeing critically ill and chronically ill patients.Dr....
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Which Combination of Drugs for Influenza?
October 29, 2009
Triple-combo Drug Shows Promise Against Antiviral Resistant H1N1 | www.medicalnewstoday.com
All 3 of these drugs are approved for use. Rimantadine is usually interchangeable with amantadine and is less toxic. Ribavirin can have very nasty side effects. Not clear from the report is whether the company is marketing a use of all 3 drugs or whether they are packaging the 3 in one pill. It isa...
The good news is that these drugs are already approved
October 28, 2009
Peter Bornstein, MD, Partner and Consultant in Infectious Diseases, St. Paul Infectious Disease Associates, Ltd
Triple-combo Drug Shows Promise Against Antiviral Resistant H1N1 | www.medicalnewstoday.com
Adamas has a proprietary mixture of three drugs: amantadine, oseltamivir and ribavirin to treat antiviral resistant strains of novel H1N1 Influenza A.
Starpharma gets US patent for use of VivaGel for protection against STIs
September 29, 2009
Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER
Starpharma gets US patent for use of VivaGel for protection against STIs | www.pharmabiz.com
Starpharma's lead product, is a vaginal microbicide gel under development for the prevention of sexually transmitted infections (STIs), including genital herpes and HIV infection. The VivaGel® product concept is designed to offer a safe, convenient and affordable means for women to protect themselves...
Stelara new Option for Psoriasis
September 26, 2009
Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER
Stelara Approved to Treat Moderate to Severe Plaque Psoriasis in Adults | www.webmd.com
The FDA approved Stelara based on three studies of 2,266 patients who either got shots of Stelara or a placebo. Patients who got Stelara were more likely to achieve the studies' benchmark for reduction in psoriasis.In a news release, the FDA notes that because Stelara reduces the immune system's ability...
Earlier Treatment Just Makes Sense
July 19, 2009
AIDS treatment should start sooner, study finds | news.yahoo.com
These data will help justify earlier treatment of patients infected with HIV, before damage to the immune system occurs.
Leading Experts in Cubicin Prescribers (US) Study Group have not participated in any upcoming seminars.
View All GLG Live Meetings in Healthcare
Leading Experts in Cubicin Prescribers (US) have not participated in any GLG webcasts.